Literature DB >> 24551268

Treg cells: a potential regulator for IL-22 expression?

Shuman Lin1, Xuyan Yang2, Dian Liang1, Song Guo Zheng3.   

Abstract

Inteleurkin-22 (IL-22) is a IL-10 family cytokine member and is mainly produced by innate lymphoid cells (ILCs), Th17 cells, and Th22 cells. Previous studies have indicated that IL-23 and several transcription factors, including STAT3, RORγt, and the AhR are important stimulus. Recently, there is emerging evidence that Tregs can regulate IL-22 expression. In the review, we discuss the updated advancement on Tregs function and its regulatory role on IL-22 expression.

Entities:  

Keywords:  Interleukin-22; T helper cells; innate immune cells; regulatory (Treg) cells

Mesh：

Substances：

Year:  2014        PMID： 24551268      PMCID： PMC3925892     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  64 in total

1.  Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot.

Authors:  Xiaohui Zhou; Julie Wang; Wei Shi; David D Brand; Zhongmin Liu; Huimin Fan; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2010-04-29       Impact factor: 6.216

2.  Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments.

Authors:  Dorothea Busse; Maurus de la Rosa; Kirstin Hobiger; Kevin Thurley; Michael Flossdorf; Alexander Scheffold; Thomas Höfer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

Review 3.  Biology of interleukin-22.

Authors:  Kerstin Wolk; Ellen Witte; Katrin Witte; Katarzyna Warszawska; Robert Sabat
Journal:  Semin Immunopathol       Date:  2010-02-02       Impact factor: 9.623

4.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

5.  CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.

Authors:  Song Guo Zheng; Ju Hua Wang; Michael N Koss; Francisco Quismorio; J Dixon Gray; David Allen Horwitz
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

6.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

7.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

8.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease.

Authors:  Kerstin Wolk; Ellen Witte; Ute Hoffmann; Wolf-Dietrich Doecke; Stefanie Endesfelder; Khusru Asadullah; Wolfram Sterry; Hans-Dieter Volk; Bianca Maria Wittig; Robert Sabat
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422
View more
  12 in total

Review 1.  Role of interleukin-22 in inflammatory bowel disease.

Authors:  Lin-Jing Li; Chen Gong; Mei-Hua Zhao; Bai-Sui Feng
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 2.  Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis.

Authors:  Li-Sha Cheng; Yun Liu; Wei Jiang
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  A protocol for humanized synovitis mice model.

Authors:  Junlong Dang; Shangling Zhu; Julie Wang
Journal:  Am J Clin Exp Immunol       Date:  2019-10-15

4.  Decreased Serum Level of Interleukin-22 Correlates with Hepcidin in Patients with Hidradenitis Suppurativa.

Authors:  Malgorzata Ponikowska; Łukasz Matusiak; Monika Kasztura; Ewa Jankowska; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2021-09-22       Impact factor: 3.875

5.  Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice.

Authors:  G H Zhao; Y Q Fang; U Ryan; Y X Guo; F Wu; S Z Du; D K Chen; Q Lin
Journal:  Parasitol Res       Date:  2015-11-23       Impact factor: 2.289

6.  Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.

Authors:  Melody Abikhair Burgo; Nazanin Roudiani; Jie Chen; Alexis L Santana; Nicole Doudican; Charlotte Proby; Diane Felsen; John A Carucci
Journal:  JCI Insight       Date:  2018-09-06

Review 7.  Computational modeling of heterogeneity and function of CD4+ T cells.

Authors:  Adria Carbo; Raquel Hontecillas; Tricity Andrew; Kristin Eden; Yongguo Mei; Stefan Hoops; Josep Bassaganya-Riera
Journal:  Front Cell Dev Biol       Date:  2014-07-29

8.  Chronic Rhinosinusitis with Polyps Is Characterized by Increased Mucosal and Blood Th17 Effector Cytokine Producing Cells.

Authors:  Dijana Miljkovic; Alkis J Psaltis; Peter J Wormald; Sarah Vreugde
Journal:  Front Physiol       Date:  2017-12-19       Impact factor: 4.566

9.  Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.

Authors:  Markus Fehrholz; Kirsten Glaser; Silvia Seidenspinner; Barbara Ottensmeier; Tore Curstedt; Christian P Speer; Steffen Kunzmann
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.

Authors:  Rose M Gilbert; Xiaozhe Zhang; Robert D Sampson; Michael R Ehrenstein; Dao X Nguyen; Mahid Chaudhry; Charles Mein; Nadiya Mahmud; Grazyna Galatowicz; Oren Tomkins-Netzer; Virginia L Calder; Sue Lightman
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.